Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 123

1.

Association between vitamin D receptor gene Cdx2 polymorphism and breast cancer susceptibility.

Zhou ZC, Wang J, Cai ZH, Zhang QH, Cai ZX, Wu JH.

Tumour Biol. 2013 Dec;34(6):3437-41. doi: 10.1007/s13277-013-0919-4. Epub 2013 Jul 3.

PMID:
23821301
2.

Vitamin D receptor Cdx-2 polymorphism and premenopausal breast cancer risk in southern Pakistani patients.

Iqbal Mu, Khan TA, Maqbool SA.

PLoS One. 2015 Mar 23;10(3):e0122657. doi: 10.1371/journal.pone.0122657. eCollection 2015 Mar 23.

3.

Associations between vitamin D receptor polymorphisms and breast cancer risk.

Wang J, He Q, Shao YG, Ji M, Bao W.

Tumour Biol. 2013 Dec;34(6):3823-30. doi: 10.1007/s13277-013-0967-9. Epub 2013 Jul 31.

PMID:
23900677
4.

Cdx-2 polymorphism in the promoter region of the human vitamin D receptor gene determines susceptibility to fracture in the elderly.

Fang Y, van Meurs JB, Bergink AP, Hofman A, van Duijn CM, van Leeuwen JP, Pols HA, Uitterlinden AG.

J Bone Miner Res. 2003 Sep;18(9):1632-41.

5.

Meta-analysis of the relation between vitamin D receptor gene BsmI polymorphism and susceptibility to ovarian cancer.

Zhang Y, Tong SC, Guan LH, Na F, Zhao W, Wei L.

Tumour Biol. 2013 Dec;34(6):3317-21. doi: 10.1007/s13277-013-0900-2. Epub 2013 Jun 20.

PMID:
23784456
6.

Vitamin D receptor gene ApaI polymorphism and breast cancer susceptibility: a meta-analysis.

Luo S, Guo L, Li Y, Wang S.

Tumour Biol. 2014 Jan;35(1):785-90. doi: 10.1007/s13277-013-1107-2. Epub 2013 Sep 19.

PMID:
24048755
7.

The Cdx-2 polymorphism in the VDR gene is associated with increased risk of cancer: a meta-analysis.

Huang J, Huang J, Ma Y, Wang H, Yang J, Xiong T, Du L.

Mol Biol Rep. 2013 Jul;40(7):4219-25. doi: 10.1007/s11033-013-2503-9. Epub 2013 May 7.

PMID:
23649760
8.

Association between FAS 1377G>A polymorphism and breast cancer susceptibility: a meta-analysis.

Li K, Li W, Zou H, Zhao L.

Tumour Biol. 2014 Jan;35(1):351-6. doi: 10.1007/s13277-013-1048-9. Epub 2013 Aug 27.

PMID:
23979975
9.

Cdx2 polymorphism affects the activities of vitamin D receptor in human breast cancer cell lines and human breast carcinomas.

Pulito C, Terrenato I, Di Benedetto A, Korita E, Goeman F, Sacconi A, Biagioni F, Blandino G, Strano S, Muti P, Mottolese M, Falvo E.

PLoS One. 2015 Apr 7;10(4):e0124894. doi: 10.1371/journal.pone.0124894. eCollection 2015 Apr 7.

10.

The VDR gene FokI polymorphism and ovarian cancer risk.

Xu H, Li S, Qiu JQ, Gao XL, Zhang P, Yang YX.

Tumour Biol. 2013 Dec;34(6):3309-16.

PMID:
24078452
11.

Meta-analysis on vitamin D receptor and cancer risk: focus on the role of TaqI, ApaI, and Cdx2 polymorphisms.

Serrano D, Gnagnarella P, Raimondi S, Gandini S.

Eur J Cancer Prev. 2016 Jan;25(1):85-96. doi: 10.1097/CEJ.0000000000000132.

12.

Association between vitamin D receptor poly(A) polymorphism and breast cancer risk: a meta-analysis.

Xu J, Li H, Gu L, Zhou X.

Tumour Biol. 2014 Jan;35(1):589-93. doi: 10.1007/s13277-013-1082-7. Epub 2013 Sep 15.

PMID:
24037913
13.

Three novel functional polymorphisms in the promoter of FGFR2 gene and breast cancer risk: a HuGE review and meta-analysis.

Zhou L, Yao F, Luan H, Wang Y, Dong X, Zhou W, Wang Q.

Breast Cancer Res Treat. 2012 Dec;136(3):885-97. doi: 10.1007/s10549-012-2300-5. Epub 2012 Nov 4. Review.

PMID:
23124475
14.

Single nucleotide polymorphism 6q25.1 rs2046210 and increased risk of breast cancer.

Pei J, Li F, Wang B.

Tumour Biol. 2013 Dec;34(6):4073-9. doi: 10.1007/s13277-013-0997-3. Epub 2013 Jul 26.

PMID:
23888322
15.

CDX2 VDR polymorphism and colorectal cancer.

Slattery ML, Herrick J, Wolff RK, Caan BJ, Potter JD, Sweeney C.

Cancer Epidemiol Biomarkers Prev. 2007 Dec;16(12):2752-5.

16.

TNFalpha -308 G/A polymorphism is associated with breast cancer risk: a meta-analysis involving 10,184 cases and 12,911 controls.

Fang F, Yao L, Yu XJ, Yu L, Wu Q, Yu L.

Breast Cancer Res Treat. 2010 Jul;122(1):267-71. doi: 10.1007/s10549-009-0698-1. Epub 2009 Dec 25.

PMID:
20035378
17.

Association between FAS A670G polymorphism and susceptibility to cervical cancer: evidence from a meta-analysis.

Shen J, Sun NX.

Tumour Biol. 2013 Dec;34(6):3443-8. doi: 10.1007/s13277-013-0920-y. Epub 2013 Jul 31.

PMID:
23900676
18.

Vitamin D receptor FokI gene polymorphism and tuberculosis susceptibility: a meta-analysis.

Sun YP, Cai QS.

Genet Mol Res. 2015 Jun 11;14(2):6156-63. doi: 10.4238/2015.June.9.1.

19.

VDR and SRD5A2 polymorphisms combine to increase risk for prostate cancer in both non-Hispanic White and Hispanic White men.

Torkko KC, van Bokhoven A, Mai P, Beuten J, Balic I, Byers TE, Hokanson JE, Norris JM, BarĂ³n AE, Lucia MS, Thompson IM, Leach RJ.

Clin Cancer Res. 2008 May 15;14(10):3223-9. doi: 10.1158/1078-0432.CCR-07-4894.

20.

Vitamin D receptor gene polymorphism(s) and breast cancer risk in north Indians.

Chakraborty A, Mishra AK, Soni A, Regina T, Mohil R, Bhatnagar D, Bhatnagar A, Chintamani C, Sharma PC, Saxena S.

Cancer Detect Prev. 2009;32(5-6):386-94.

PMID:
19588543

Supplemental Content

Support Center